The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant Staphylococcus aureus Disease in San Francisco, 2004–2005
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a major public health problem in both the community and hospitals. Few studies have characterized the incidence and clonal composition of disease-causing strains in an entire population. Our objective was to perform a population-based survey of the clinical and molecular epidemiology of MRSA disease in San Francisco, California. METHODS: We prospectively collected 3985 MRSA isolates and associated clinical and demographic information over a 12-month period (2004-2005) at 9 San Francisco-area medical centers. A random sample of 801 isolates was selected for molecular analysis. RESULTS: The annual incidence of community-onset MRSA disease among San Francisco residents was 316 cases per 100,000 population, compared with 31 cases per 100,000 population for hospital-onset disease. Persons who were aged 35-44 years, were men, and were black had the highest incidence of community-onset disease. The USA300 MRSA clone accounted for 234 cases of community-onset disease and 15 cases of hospital-onset disease per 100,000 population, constituting an estimated 78.5% and 43.4% of all cases of MRSA disease, respectively. Patients with community-onset USA300 MRSA versus non-USA300 MRSA disease were more likely to be male, be of younger age, and have skin and soft-tissue infections. USA300 strains were generally more susceptible to multiple antibiotics, although decreased susceptibility to tetracycline was observed in both community-onset (P = .008) and hospital-onset (P = .03) USA300 compared to non-USA300 strains. CONCLUSIONS: The annual incidence of community-onset MRSA disease in San Francisco is substantial, surpassing that of hospital-onset disease. USA300 is the predominant clone in both the community and hospitals. The dissemination of USA300 from the community into the hospital setting has blurred its distinction as a community-associated pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Outpatient rates of community-associated MRSA infection increased sevenfold over 1999 -2006 in the USA, and subsequently became a signi fi cant cause of MRSA infections within the hospital setting [3, 11].”
From Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Self-citationLina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodMethicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285 · cited 3×
“Many studies characterizing community-associated MRSA and the USA300 strain have focused on outbreaks in particular groups [12–16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688 · cited 5×
“other studies [2, 7, 17, 38], incidence of community-onset MRSA was the highest in a younger age group (35–44 years).”
BackgroundResultInfluentialDiep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633 · cited 6×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundMethodInfluentialSelf-citationMethicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493 · cited 4×
“1086/587893 MRSA clone has become a primary cause of community-associated disease [2, 7, 8] and an increasingly important source of health care–associated infection [9, 10].”
BackgroundResultInfluentialHerold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412 · cited 1×
“Since the late 1990s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant pathogen in the community [1–6].”
BackgroundOliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343 · cited 1×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundShopsin, B., Gomez, M., Montgomery, S. O., Smith, D. H., Waddington, M., Dodge, D. E., Bost, D. A., Riehman, M., Naidich, S., & Kreiswirth, B. N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3556-3563.1999 · Cited by 984 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodCommunity-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
Research works printed but not linked: 5
- Centers, 2003, MMWR, 52, 793
- Centers, 2001, MMWR, 50, 919
- Centers, 2003, MMWR, 52, 992
- Centers, 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- 10.1111/j.1553-2712.2007.tb00368.x · doi:10.1111/j.1553-2712.2007.tb00368.x
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
“Because of the prominence of toxin activity in these infections, protein synthesis inhibition may also be desirable [54, 55].”
BackgroundLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
“community and in health care facilities [7, 8].”
Self-citationWaves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
“CA-MRSA clones have also gained a foothold in hospitals and are increasingly being identified as a cause of hospital-onset and heath care-associated infection”
BackgroundSelf-citationDavid, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
“MRSA has become increasingly complex as CA-MRSA and HA-MRSA strains have co-mingled both in the community and in health care facilities [7, 8].”
BackgroundSelf-citationCommunity-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Self-citationStefani, S., Chung, D. R., Lindsay, J. A., Friedrich, A. W., Kearns, A. M., Westh, H., & MacKenzie, F. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.030 · Cited by 590
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
Self-citationVancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
(2017) · PubMed Central
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Health Care–Associated Invasive MRSA Infections, 2005-2008
Kallen, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1115 · Cited by 439
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Livestock-Associated MRSA: The Impact on Humans
Cuny, C., Wieler, L., & Witte, W. (2015) · Antibiotics · doi:10.3390/antibiotics4040521 · Cited by 312
Bayer, A. S., Schneider, T., & Sahl, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06819.x · Cited by 311
Ray, G. T., Suaya, J. A., & Baxter, R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-252 · Cited by 281
Staphylococcus aureus in Animals
Haag, A. F., Fitzgerald, J. R., & Penadés, J. R. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0060-2019 · Cited by 257
Landrum, M. L., Neumann, C., Cook, C., Chukwuma, U., Ellis, M. W., Hospenthal, D. R., & Murray, C. K. (2012) · JAMA · doi:10.1001/jama.2012.7139 · Cited by 228
Molecular Pathogenesis of Staphylococcus aureus Infection
Liu, G. Y. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dc44d · Cited by 220
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Lee, B. Y., Singh, A., David, M. Z., Bartsch, S. M., Slayton, R. B., Huang, S. S., Zimmer, S. M., Potter, M. A., Macal, C. M., Lauderdale, D. S., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03914.x · Cited by 207
“, occurring among persons not hospitalized in the prior year) of 243 per 100,000[18].”
BackgroundAkash, M. S. H., Rehman, K., Fiayyaz, F., Sabir, S., & Khurshid, M. (2020) · Archives of Microbiology · doi:10.1007/s00203-020-01818-x · Cited by 191
Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus
Uhlemann, A.-C., Otto, M., Lowy, F. D., & DeLeo, F. R. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.04.030 · Cited by 194
“For example, by 2005 it was estimated that ∼90% of all MRSA infections in San Francisco were community-associated (Liu et al., 2008).”
BackgroundGerber, J. S., Coffin, S. E., Smathers, S. A., & Zaoutis, T. E. (2009) · Clinical Infectious Diseases · doi:10.1086/599348 · Cited by 193
Progress Toward a Staphylococcus aureus Vaccine
Daum, R. S., & Spellberg, B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir828 · Cited by 165
Lipsky, B. A., Tabak, Y. P., Johannes, R. S., Vo, L., Hyde, L., & Weigelt, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1672-5 · Cited by 162
Casey, J. A., Curriero, F. C., Cosgrove, S. E., Nachman, K. E., & Schwartz, B. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10408 · Cited by 194
“Age at infection, median (IQR), y 29 (13-48) 65 (45-77) 46 (14-61) <.”
Self-citationFritz, S. A., Hogan, P. G., Camins, B. C., Ainsworth, A. J., Patrick, C., Martin, M. S., Krauss, M. J., Rodriguez, M., & Burnham, C. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-12 · Cited by 146
Dukić, V., Lauderdale, D. S., Wilder, J. R., Daum, R. S., & David, M. Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052722 · Cited by 133
Development of a vaccine against Staphylococcus aureus
Spellberg, B. J., & Daum, R. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0293-5 · Cited by 132
“Their baseline estimate of disease burden was 38 cases per 100,000, which likely grossly underestimates (by approximately nine- or tenfold) the true incidence of MRSA infections if simple abscesses are included [13, 110].”
BackgroundSader, H. S., Fey, P. D., Fish, D. N., Limaye, A. P., Pankey, G. A., Rahal, J. J., Rybak, M. J., Snydman, D. R., Steed, L. L., Waites, K. B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-09 · Cited by 121
Nguyen, H. M., & Graber, C. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp377 · Cited by 132
Self-citationResistance surveillance studies: a multifaceted problem—the fluoroquinolone example
Dalhoff, A. (2012) · Infection · doi:10.1007/s15010-012-0257-2 · Cited by 111
Wall teichoic acids mediate increased virulence in Staphylococcus aureus
Wanner, S., Schade, J., Keinhörster, D., Weller, N., George, S. E., Kull, L., Bauer, J., Grau, T., Winstel, V., Stoy, H., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.257 · Cited by 117
Besednova, N. N., Andryukov, B. G., Zaporozhets, T. S., Kryzhanovsky, S. P., Kuznetsova, T. A., Fedyanina, L. N., Макаренкова, И. Д., & Николаевна, З. Т. (2020) · Biomedicines · doi:10.3390/biomedicines8090342 · Cited by 114
Clinical impact of antibiotic-resistant Gram-positive pathogens
Lode, H. M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02738.x · Cited by 104
“Recently, a prospective study from nine San Francisco-area medical centres found an annual incidence of community-onset MRSA disease among San Francisco residents of 316 cases/100 000 population, as compared with 31 cases/100 000 population for hospital-onset disease [28].”
BackgroundTong, S. Y. C., Chen, L. F., & Fowler, V. G. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0300-x · Cited by 122
Duane, T. M., Huston, J. M., Collom, M., Beyer, A., Parli, S. E., Buckman, S. A., Shapiro, M. A., McDonald, A. A., Diaz, J. J., Tessier, J. M., et al. (2021) · Surgical Infections · doi:10.1089/sur.2020.436 · Cited by 106
“Because of these recent findings, MRSA has become a complex bacterium with both HA-MRSA and CA-MRSA being present in the hospital and community setting [17,147].”
Diep, B. A., Afasizheva, A., Le, H. N., Kajikawa, O., Matute‐Bello, G., Tkaczyk, C., Sellman, B. R., Badiou, C., Lina, G., & Chambers, H. F. “. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit129 · Cited by 90
“fasciitis, and necrotizing pneumonia [6, 17–22].”
Self-citationSimor, A. E., Gilbert, N. L., Gravel, D., Mulvey, M. R., Bryce, E., Loeb, M., Matlow, A., McGeer, A., Louie, L., Campbell, J., et al. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651313 · Cited by 87
“5,312 (17) 26,377 (83) 11,828 (32) 25,003 (68)”
Elhassan, M. M., Ozbak, H. A., Hemeg, H. A., Elmekki, M. A., & Ahmed, L. M. (2015) · BioMed Research International · doi:10.1155/2015/895860 · Cited by 85
Mechanisms of Pyocyanin Toxicity and Genetic Determinants of Resistance in Staphylococcus aureus
Noto, M. J., Burns, W. J., Beavers, W. N., & Skaar, E. P. (2017) · Journal of Bacteriology · doi:10.1128/jb.00221-17 · Cited by 125
Wong, J., Ip, M., Tang, A., Wei, V. W. I., Wong, S. Y. S., Riley, S., Read, J. M., & Kwok, K. O. (2018) · Clinical Epidemiology · doi:10.2147/clep.s160595 · Cited by 98
“A prospective study in the USA revealed that the incidence rate of CAMRSA infections was 243 cases/100,000 population in 2005, while that of health care–associated MRSA infections was 31 cases/100,000 population.(2) CA-MRSA infections were also found among hospitalized patients,(3) signifying the infiltration of CA-MR…”
BackgroundSkov, R. L., Christiansen, K., Dancer, S. J., Daum, R. S., Dryden, M., Huang, Y., & Lowy, F. D. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.029 · Cited by 81
“[105] Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, et al.”
BackgroundYu, F., Li, T., Huang, X., Xie, J., Xu, Y., Tu, J., Qin, Z., Parsons, C. H., Wang, J., Hu, L., et al. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.015 · Cited by 78
“Pulsed-field gel electrophoresis patterns, carriage of PVL, SCCmec typing, spa typing, and multilocus sequence typing (MLST) have been proven useful for monitoring the evolutionary process of pandemic HA-MRSA and CA-MRSA clones (David and Daum, 2010; Liu et al., 2008; Liu et al., 2009).”
BackgroundStructural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus
Alexander, J. A. N., Worrall, L. J., Hu, J., Vuckovic, M., Satishkumar, N., Poon, R., Sobhanifar, S., Rosell, F. I., Jenkins, J., Chiang, D., et al. (2023) · Nature · doi:10.1038/s41586-022-05583-3 · Cited by 88
Self-citationTattevin, P., Schwartz, B. S., Graber, C. J., Volinski, J., Bhukhen, A., Bhukhen, A., Mai, T. T., Vo, N. H., Dang, D., Phan, T. H., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis527 · Cited by 78
Self-citationEom, S., Lee, D.-S., Jung, Y.-J., Park, J., Choi, J.-I., Yim, M., Jeon, J.-M., Kim, H., Son, K.-T., Je, J., et al. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6041-8 · Cited by 74
“MRSA infections are extremely difficult to treat due to their multidrug-resistant properties, which are resistant to almost all available antibiotics, and MRSA is associated with the resurgence of multidrug resistance (Lowy 1998; Liu et al. 2008).”
BackgroundAntri, K., Rouzic, N., Dauwalder, O., Boubekri, I., Bes, M., Lina, G., Vandenesch, F., Tazir, M., Ramdani‐Bouguessa, N., & Étienne, J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03273.x · Cited by 66
Casey, J. A., Cosgrove, S. E., Stewart, W. F., Pollak, J., & Schwartz, B. S. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812001872 · Cited by 73
Self-citationCommunity-Associated Methicillin-Resistant Staphylococcus aureus Case Studies
Sowash, M. G., & Uhlemann, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_2 · Cited by 72
Liu, H., Xu, T., Xue, Z., Huang, M., Wang, T., Zhang, M., Yang, R., & Guo, Y. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00647 · Cited by 62
Evolving Epidemiology ofStaphylococcus aureusBacteremia
Rhee, Y., Aroutcheva, A. A., Hota, B. N., Weinstein, R. A., & Popovich, K. J. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.213 · Cited by 64
Point-Counterpoint: To Screen or Not To Screen for Methicillin-Resistant Staphylococcusaureus
Peterson, L. R., & Diekema, D. J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02516-09 · Cited by 59
Asghar, A. H. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.304.4946 · Cited by 76
Jenkins, T. C., McCollister, B. D., Sharma, R., McFann, K., Madinger, N. E., Barron, M. A., Bessesen, M. T., Price, C. S., & Burman, W. J. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/595963 · Cited by 63
Ray, G. T., Suaya, J. A., & Baxter, R. P. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00134-12 · Cited by 59
Wilson, B. A., Garud, N. R., Feder, A. F., Assaf, Z. J. F., & Pennings, P. S. (2015) · Molecular Ecology · doi:10.1111/mec.13474 · Cited by 65
“90% of MRSA infections were acquired in the community (Liu et al. 2008).”
BackgroundMa, X., Chang, W., Zhang, C., Zhou, X., & Yu, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034970 · Cited by 66
Hetem, D. J., Westh, H., Boye, K., Jarløv, J. O., Bonten, M. J. M., & Bootsma, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks125 · Cited by 54
DeLorenze, G. N., Nelson, C. L., Scott, W. K., Allen, A. S., Ray, G. T., Tsai, A., Quesenberry, C. P., & Fowler, V. G. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv483 · Cited by 60
“the first isolate per person in a 365-day period [13, 14].”
BackgroundStaphylococcus aureusInfections in US Veterans, Maryland, USA, 1999–20081
Tracy, L. A., Furuno, J. P., Harris, A. D., Singer, M. E., LANGENBERG, P. W., & Roghmann, M. (2011) · Emerging infectious diseases · doi:10.3201/eid1707.100502 · Cited by 62
Ellis, M. W., Griffith, M. E., Jorgensen, J. H., Hospenthal, D. R., Mende, K., & Patterson, J. E. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-08 · Cited by 50
“Prior investigations have identified USA300 as a particularly virulent pulsed-field type, causing the majority of reported MRSA infections in community settings (13, 20, 21, 24 , 28, 31).”
BackgroundInfluentialPatel, M. (2009) · Drugs · doi:10.2165/00003495-200969060-00004 · Cited by 58
“Several studies suggest that community strains of MRSA are replacing or adding to the traditional nosocomial strains of MRSA in many populations.([108-110]) Defining CA- and HA-MRSA on clinical risk factors alone is becoming less useful as these strains intermingle within the healthcare setting.”
BackgroundMethicillin‐ResistantStaphylococcus aureus: An Update
Durai, R., Ng, P. C., & Hoque, H. (2010) · AORN Journal · doi:10.1016/j.aorn.2009.11.065 · Cited by 63
von Dach, E., Diene, S. M., Fankhauser, C., Schrenzel, J., Harbarth, S., & François, P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv489 · Cited by 59
“In the United States, USA300 (ST8-SCC mec IVa) isolates are the predominant cause of community-associated MRSA (CA-MRSA) infections, accounting for up to 90% of MRSA infections in some areas [7].”
BackgroundResultOlsen, R. J., Kobayashi, S. D., Ayeras, A. A., Ashraf, M., Graves, S. F., Ragasa, W., Humbird, T. L., Greaver, J. L., Cantu, C., Swain, J. L., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090960 · Cited by 55
Joo, E., Chung, D. R., Ha, Y. E., Park, S. Y., Kang, S., Kim, S. H., Kang, C., Peck, K. R., Lee, N. Y., Ko, K. S., et al. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.04.018 · Cited by 48
Methicillin-ResistantStaphylococcus aureus: A Community Health Threat
Cataldo, M. A., Taglietti, F., & Petrosillo, N. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2218 · Cited by 55
Hudson, L. O., Reynolds, C. A., Spratt, B. G., Enright, M. C., Quan, V., Kim, D. H., Hannah, P., Mikhail, L., Alexander, R. C., Moore, D. F., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01708-13 · Cited by 47
Self-citationEvolutionary epidemiology 20 years on: Challenges and prospects
Restif, O. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.09.007 · Cited by 52
Pitz, A. M., Yu, F., Hermsen, E. D., Rupp, M. E., Fey, P. D., & Olsen, K. M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00914-10 · Cited by 48
Lam, J. C., Gregson, D. B., Robinson, S., Somayaji, R., Conly, J. M., & Parkins, M. D. (2019) · Infection · doi:10.1007/s15010-019-01330-5 · Cited by 43
How to stratify patients at risk for resistant bugs in skin and soft tissue infections?
Guillamet, C. V., & Kollef, M. H. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000244 · Cited by 45
Lee, G. C., Dallas, S. D., Wang, Y., Olsen, R. J., Lawson, K. A., Wilson, J. P., & Frei, C. R. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx200 · Cited by 42
Rodriguez, M., Hogan, P. G., Satola, S. W., Crispell, E. K., Wylie, T., Gao, H., Sodergren, E. J., Weinstock, G. M., Burnham, C. D., & Fritz, S. A. (2015) · Medicine · doi:10.1097/md.0000000000001534 · Cited by 40
“MSSA (61) IV (44) RT 16 (21) ST 8 (37) USA 300 (46) t008 (35) MRSA (39) III (6) RT 17 (21) ST 5 (9) USA 200 (11) t002 (5) NEGy (46) RT 3 (13) ST 30 (9) USA 800 (9) RT 20 (10) ST 72 (6) USA 600 (8) RT 4 (5) ST 45 (5) USA 900 (5) RT 24 (5) ST 15 (5) ST 59 (5)”
The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
Lagacé, F., D’Aguanno, K., Prosty, C. J., Laverde‐Saad, A., Cattelan, L., Ouchene, L., Oliel, S., Genest, G., Doiron, P., Richer, V., et al. (2023) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754231177582 · Cited by 49
Hudson, L. O., Murphy, C. R., Spratt, B. G., Enright, M. C., Elkins, K. R., Nguyen, C., Terpstra, L., Gombosev, A., Kim, D. H., Hannah, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062117 · Cited by 45
Self-citationFreitas, E. A., Harris, R. M., Blake, R. K., & Salgado, C. D. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651672 · Cited by 39
“Although the definition of CA-MRSA has varied among studies (ie, defined on the basis of healthcare exposure or PFGE pattern), the majority have observed that African American or minority race has been associated with increased risk for CA-MRSA infection.(18,29,30) The role of race as a risk could be a reflection of s…”
BackgroundResultInfluentialBrunati, C., Thomsen, T. T., Gaspari, E., Maffioli, S. I., Sosio, M., Jabes, D. L., Løbner‐Olesen, A., & Donadio, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx395 · Cited by 38
Nickerson, E. K., Wuthiekanun, V., Kumar, V. S., Amornchai, P., Wongdeethai, N., Chheng, K., Chantratita, N., Putchhat, H., Thaipadungpanit, J., Day, N., et al. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0300 · Cited by 37
Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic
Jamrozy, D. M., Harris, S. R., Mohamed, N., Peacock, S. J., Tan, C. Y., Parkhill, J., Anderson, A. S., & Holden, M. T. G. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000058 · Cited by 43
“In the healthcare setting, USA300 was reported to emerge alongside established HA-MRSA clones (Chua et al., 2008; Limbago et al., 2009; Pasquale et al., 2013; Tattevin et al., 2009) or to replace them (Carey et al., 2010; Liu et al., 2008).”
BackgroundCurrent status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China
Li, T., Song, Y. J., Zhu, Y., Du, X., & Li, M. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-153 · Cited by 35
Wang, W., Lee, S.-Y., Chiueh, T., & Lu, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00539-09 · Cited by 40
Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring
Swartling, M., Gupta, R., Dudas, V., & Guglielmo, B. J. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9614-6 · Cited by 34
“The annual incidence of community-onset MRSA in San Francisco was 316 cases per 100 000 population, compared to only 31 cases per 100 000 population for nosocomial cases [2].”
BackgroundHolzknecht, B. J., Harðardóttir, H., Haraldsson, G., Westh, H., Valsdóttir, F., Boye, K., Karlsson, S. M., Kristinsson, K. G., & Guðlaugsson, Ó. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01382-10 · Cited by 42
Bartels, M. D., Kristoffersen, K., Boye, K., & Westh, H. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02829.x · Cited by 35
“USA300 (ST8-IV) is the dominant CA-MRSA in the USA [2,9], whereas ST30-IV has mostly been described in Australasia, where it is known as the Southwest Pacific clone or the Western Samoan phage pattern [10,11].”
BackgroundTseng, S., Hung, W., Chen, H.-J., Lin, Y.-T., Jiang, H.-S., Chiu, H., Hsueh, P., Teng, L., & Tsai, J. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.12.007 · Cited by 33
Djoudi, F., Bonura, C., Benallaoua, S., Touati, A., Touati, D., Aléo, A., Calà, C., Fasciana, T., & Mammina, C. (2013) · PubMed · Cited by 36
Community-associated Methicillin-resistant Staphylococcus aureus Skin Infections in the Tropics
Tong, S. Y. C., Steer, A. C., Jenney, A. W. J., & Carapetis, J. R. (2010) · Dermatologic Clinics · doi:10.1016/j.det.2010.09.005 · Cited by 32
Tsuji, B. T., Brown, T., Parasrampuria, R., Brazeau, D. A., Forrest, A., Kelchlin, P. A., Holden, P. N., Peloquin, C. A., Hanna, D. L., & Bulitta, J. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05453-11 · Cited by 32
Principles of Anti-Infective Therapy
Eliopoulos, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00287-6 · Cited by 31
Invasive community-associated MRSA infections: epidemiology and antimicrobial management
Pichereau, S., & Rose, W. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.511614 · Cited by 31
“A recent review [10] of CA-MRSA from four observations [5-7,11] described that roughly 90% of CA-MRSA infections occur in SSTI, of which 90% are abscesses and/or cellulitis [5] with purulent drainage [12].”
BackgroundStaphylococcus aureus – antimicrobial resistance and the immunocompromised child
McNeil, J. C. (2014) · Infection and Drug Resistance · doi:10.2147/idr.s39639 · Cited by 30
Internet Queries and Methicillin-ResistantStaphylococcus aureusSurveillance
Dukić, V., David, M. Z., & Lauderdale, D. S. (2011) · Emerging infectious diseases · doi:10.3201/eid/1706.101451 · Cited by 27
Benton, C. H., Delahay, R. J., Trewby, H., & Hodgson, D. J. (2014) · European Journal of Wildlife Research · doi:10.1007/s10344-014-0882-4 · Cited by 29
“…College of Life and Environmental Sciences, Penryn Campus, Penryn TR10 9EZ, UK disease strains has helped uncover drivers of disease transmission (Liu et al. 2008), infer the geographic origin of pathogens (Hemelaar et al. 2011) and provided a baseline against which changes can be detected…”
BackgroundBotelho-Nevers, É., Verhoeven, P. O., Paul, S., Grattard, F., Pozzetto, B., Berthelot, P., & Lucht, F. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.840091 · Cited by 27
MRSA Infections: From Classical Treatment to Suicide Drugs
Drebes, J., Künz, M., Pereira, C. A., Betzel, C., & Wrenger, C. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867320666131119122520 · Cited by 33
Metadata
- Authors
- Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., Gordon, S., Gunthorpe, H., Jacobs, R., Jensen, P., Leoung, G., Rumack, J. S., & Chambers, H. F.
- Affiliations
- San Francisco General Hospital (US)
- Imperial College London (GB)
- California Pacific Medical Center (US)
- St. Mary's Medical Center (US)
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Saint Francis Memorial Hospital (US)
- Seton Medical Center (US)
- Corresponding author
- Liu, Catherine
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06
- Volume
- 46
- Issue
- 11
- Pages
- 1637-1646
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2098229782
- Cited by
- 205
- References
- 41
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 5 · 2015: 17 · 2014: 13 · 2013: 21 · 2012: 28
- FWCI
- 16.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- Centers for Disease Control and Prevention
- U.S. Public Health Service (CCR923381)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- methicillin-resistant Staphylococcus aureus, USA300 clone, molecular epidemiology, clonal composition, antibiotic susceptibility, tetracycline resistance, skin and soft tissue infections, San Francisco
- MeSH terms
- Adult, Female, Humans, Male, Population Surveillance, Prospective Studies, San Francisco, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, Methicillin Resistance, Community-Acquired Infections, Molecular Epidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.